Evidence map›Paper›PMID 25149170›Full record

ArticleCurrent allergy and asthma reports2014

Utility of next generation sequencing in clinical primary immunodeficiencies.

Nikita Raje, Sarah Soden, Douglas Swanson, Christina E Ciaccio, Stephen F Kingsmore, Darrell L Dinwiddie

Open access · greenAbstract read
In one paragraph

Article in Current allergy and asthma reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Primary Immunodeficiencies: Diseases of Children and Adults - A Review.Advances in experimental medicine and biology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Utilization of genomic sequencing for population screening of immunodeficiencies in the newborn.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  18. Article
  19. Article
  20. Exome and genome sequencing for inborn errors of immunity.The Journal of allergy and clinical immunology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Nikita RajeChildren's Mercy Hospital, 2401 Gillham Road, Kansas City, MO, 64108, USA, nraje@cmh.edu.
Sarah Soden
Douglas Swanson
Christina E Ciaccio
Stephen F Kingsmore
Darrell L Dinwiddie
Children's Mercy Hospital · USUniversity of Missouri–Kansas City · USMercy Hospital · USUniversity of New Mexico · US

Funding

Heartland Institute for Clinical and Translational ResearchUL1TR000001 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$13.0M
University of New Mexico Clinical and Translational Science CenterKL2TR000089 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$909k
NCATS NIH HHS KL2 TR000089NCATS NIH HHS UL1 TR000001
6 · The paper itself

Abstract

Primary immunodeficiencies (PIDs) are a group of genetically heterogeneous disorders that present with very similar symptoms, complicating definitive diagnosis. More than 240 genes have hitherto been associated with PIDs, of which more than 30 have been identified in the last 3 years. Next generation sequencing (NGS) of genomes or exomes of informative families has played a central role in the discovery of novel PID genes. Furthermore, NGS has the potential to transform clinical molecular testing for established PIDs, allowing all PID differential diagnoses to be tested at once, leading to increased diagnostic yield, while decreasing both the time and cost of obtaining a molecular diagnosis. Given that treatment of PID varies by disease gene, early achievement of a molecular diagnosis is likely to enhance treatment decisions and improve patient outcomes.

Indexed as

High-Throughput Nucleotide SequencingSequence Analysis, DNADiagnosis, DifferentialExomeGenetic MarkersGenetic TestingGenome, HumanHumansImmunologic Deficiency SyndromesPolymorphism, Single NucleotideGenetic Markers

Identifiers

PMID25149170
PMCPMC4582650
OpenAlexW2078468136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.